Greg Ash

Greg Ash Email and Phone Number

Vice President | Strategy | Oncology | Sales Management | Marketing | Servant And Cross-functional Team Leadership | Strategic Thinking | Change Management | Lead @ Caris Life Sciences
Greg Ash's Location
Greater Chicago Area, United States, United States
Greg Ash's Contact Details
About Greg Ash

Executive Sales Management: Developed value proposition, business strategy, national sales force expansion, operations and cross functional synergy, projections and capacity analysis for venture capital presentation, funding, and a strong exit value. Lead national sales teams of experienced, professional molecular oncology diagnostic sales professionals. Develop national sales strategy to deliver against direct sales revenue objectives. Establish senior level relationships within key accounts. Successfully build and manage a sales team and coordinate with HR on staffing needs. Oncology: Hospital and clinic oncologists, pathologists, buy and bill, Medicare Part B, contracting, coding, reimbursement, KOL and speaker development, specialty pharmacy, implantable device sales, injectable experience and molecular oncology diagnostics. * 18 years in biotech, specialty oncology pharmaceuticals, and molecular oncology diagnostics.* Solid tumor, hematologic malignancies and hereditary cancers. Prognostic and predictive personalized medicine and associated actionable biomarker testing: Targeted therapies are directed at unique molecular features of cancer, potentially reducing cost and improving patient outcomes.* President's Club Award Winner* Above and Beyond Award WinnerSpecialties: Executive Sales Management, Marketing, and OperationsMolecular Oncology DiagnosticsHematology/Oncology:- Immuno-Oncology- Liquid Biopsy - Lung Cancer- Breast Cancer- Colorectal Cancer- Prostate Cancer- Melanoma- Myelodysplastic Syndrome, Leukemia- Non-Hodgkin's Lymphoma- Hereditary - Gastric Cancer- Oncology Personalized Medicine, Predictive Biomarkers

Greg Ash's Current Company Details
Caris Life Sciences

Caris Life Sciences

View
Vice President | Strategy | Oncology | Sales Management | Marketing | Servant And Cross-functional Team Leadership | Strategic Thinking | Change Management | Lead
Greg Ash Work Experience Details
  • Caris Life Sciences
    Vice President, Strategic Account Management
    Caris Life Sciences Jan 2024 - Present
    Irving, Texas, Us
  • Oncohost
    Regional Sales Director
    Oncohost Jul 2023 - Jan 2024
    Binyamina, Israel, Il
  • Foundation Medicine
    Associate Director - Health Systems National Accounts
    Foundation Medicine Mar 2021 - May 2023
    Boston, Massachusetts, Us
    Accountable for the success of U.S. Health System National Accounts targeting > $36MM in business. Bridge cross functional teams and oversaw overall objectives, strategy and execution to align to corporate goals for National Health Systems. Deliver innovative mindset in strategic problem solving. Leverage firm understanding of core business, market and competitive landscape and critically evaluate the impact of those factors to implement counter strategy. Inspire team to achieve outstanding performance and deliver results aligned with company's mission.Navigate complex National Health Systems, GPOs and IDNs quickly evolving marketplace, communicate to and influence Executive team to inform strategy to AOP objectives.Create National Healthy System Strategy and ExecutionCreate and present Value Proposition, Business Reviews and Business Plans to monitor performance and adjust as necessaryDevelop key relationships and understand customer strategic priorities to drive adoption of mutually beneficial solutionProvide regular visibility for management and staff on industry trends, best practices, and competitive insights
  • Foundation Medicine
    Associate Director - Great Lakes Region
    Foundation Medicine Feb 2018 - Mar 2021
    Boston, Massachusetts, Us
    Executive LeadershipAccountable for the success of Great Lakes sales region organization; 8 person team and a $25 to 30MM business. Bridged cross functional knowledge and oversaw overall objectives, strategy and execution to align to corporate goals. Apply exceptional innovative mindset in strategic problem solving. Leverage firm understanding of core business, industry and competitive landscape and critically evaluate the impact of those factors to implement counter strategy. Focus on developing leaders, as well as activating and empowering teams. Inspire team to achieve exceptional performance and deliver results aligned with Foundation Medicine's mission.• Navigate complex, quickly evolving marketplace, communicate to and influence Executive team to inform strategy to AOP objectives• Present Quarterly Business Reviews and Monthly Business Plans to monitor performance and adjust as necessary• Experience successfully launching products; executed 2 FDA-approved companion diagnostic launchesExpertise in change management, building new organizational teams and deliberately organizing to meet the needs of the market• Evaluated business needs, matched resources, aligned headcount investments, redesigned commercial organization (sales, key accounts, insights, customer experience), orchestrated interview teams, placement procedures, job descriptions, customer engagement model/role clarity*Technology: CDx, NGS (Next Generation Sequencing), RT-PCR, FISH, IHC, Plasma DNA/CTCs and Tech Only services• Co-Chair, Cross Functional Leadership: Led national Marketing Insights Team• 2019 Essence Award Winner, West Area Regional Sales Leader - selected by my peers (other Regional Sales Leaders) for embodying Foundation Medicine's core values of patients, passion, innovation and collaboration
  • Cancer Genetics, Inc.
    Vice President Of Sales - Molecular Oncology Diagnostics
    Cancer Genetics, Inc. Mar 2015 - 2018
    Cherry Hill, Nj, Us
    • Executive Sales Management: Lead a National sales team of 3 Regional Directors and over 10 experienced, professional molecular oncology diagnostic sales professionals* Develop national sales strategy to deliver against direct sales revenue objectives• Establish senior level relationships within key accounts• Successfully build and manage a sales team and coordinate with HR on staffing needs• Demonstrate extensive pharmaceutical experience specializing in oncology, targeted therapies encompassing multiple cancer disease states for not only solid but also hematologic malignancies as well as the associated bio-marker testing• Provide regular visibility for management and staff on industry trends, best practices, and competitive insights• Analyze business opportunities and develop strategic sales plans • Demonstrate extensive "Core" level knowledge of molecular oncology diagnostic testing for oncology, pathology, technology solutions, and competitive strategies through the use of company resources, on the job training, in house literature, marketing material, and clinical studies | Immuno-Oncology - PD-L1 Testing | Lung Cancer | Liquid Biopsy | Colorectal Cancer | Breast Cancer | Melanoma Cancer | Hematology: AML,CML, CLL, MM, NHL/HL... | Hereditary: BRCA 1/2, Hereditary panel testingRelated Targeted Therapies:Keytruda (Pembrolizumab), Opdivo (nivolumab), Erlotinib (Tarceva), Pemetrexed (Alimta), Cetuximab (Erbitux), Bevacizumab Injection (Avastin), Carboplatin (Platinum), Cisplatin (Platinum), FOLFOX (FOL– Folinic acid (leucovorin), Fluorouracil (5-FU), OX – Oxaliplatin (Eloxatin), FOLFIRI (IRI- Irinotecan), Gemcitabine, Crizotinib (XALKORI®), Vemurafenib * Call Points: National, Regional, Strategic, and System Oncology, Pathology Focus* Academic, Independent, community and hospital Contracting * Collaborative Research Studies with Major Teaching and Academic Hospitals * Brand Marketing And Launch * Buy and Bill
  • Www.Gopathdx.Com
    Vice-President Of Sales And Marketing - Molecular Oncology Diagnostics
    Www.Gopathdx.Com Mar 2014 - Mar 2015
    • Developed Value Proposition, business strategy, national sales force expansion, operations and cross functional synergy, projections and capacity analysis for venture presentation, funding and a strong exit value • Successfully build and manage a sales team and coordinate with HR on staffing needs• Build and foster strong cross-functional internal relationships to facilitate efficient processes for product development, pipeline management, compensation plans, sales reporting, and revenue forecasting.• Demonstrate extensive pharmaceutical experience specializing in oncology, targeted therapies encompassing multiple cancer disease states for not only solid but also hematologic malignancies as well as the associated bio-marker testing• Provide regular visibility for management and staff on industry trends, best practices, and competitive insights• Analyze business opportunities and develop strategic sales plans • Provides necessary and appropriate post-sales service to accounts, utilizing each opportunity to discover and pursue additional business• Demonstrate extensive "Core" level knowledge of not only molecular oncology but also molecular oncology diagnostic testing for pathology, technology solutions and competitive strategies through the use of company resources, on the job training, in house literature, marketing material, and clinical studies* NGS, IHC, PCR, FISH
  • Response Genetics
    Director Of Strategic Accounts | Molecular Oncology Diagnostics
    Response Genetics Jul 2011 - Jan 2014
    • Working in conjunction with product, analytics and operations divisions to help identify, architect, negotiate, and close large scale accounts thru out the country •Positioning and maintaining Response Genetics as a leader in high clinical utility and cutting edge oncology molecular diagnostics•Sell comfortably in a team-sell format to C-level executives of large accounts •Develop strategic business plans for key accounts designed to increase account penetration resulting in significant revenue growth• Facilitate ongoing sales training and career development• Develop critical accounts with leading account executives in a teamwork approach | Lung Cancer | Colorectal Cancer | Breast Cancer | Melanoma Cancer | Gastric CancerResponseDX: Lung™, ResponseDX: Colon™, ResponseDX: Gastric™, ResponseDX: Melanoma™—to help physicians with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC) EGFR, EML4-ALK, c-Met, ROS-1, PI3Kinase, KRAS, ERCC-1; Colorectal Cancer (CRC) KRAS, BRAF, NRAS, PI3, MSI, c-Met, PI3Kinase, ERCC1, EGFR, TS; Gastric Cancer (GC) HER2; and Melanoma BRAF. Related Targeted Therapies: Erlotinib (Tarceva), Pemetrexed (Alimta), Cetuximab (Erbitux), Bevacizumab Injection (Avastin), Carboplatin (Platinum), Cisplatin (Platinum), FOLFOX (FOL– Folinic acid (leucovorin), Fluorouracil (5-FU), OX – Oxaliplatin (Eloxatin), FOLFIRI (IRI- Irinotecan), Gemcitabine, Crizotinib (XALKORI®), Vemurafenib (Zelboraf) * Call Points: National, Regional, Strategic, and System Oncology, Pathology Focus* Academic, Independent, community and hospital Contracting * Collaborative Research Studies with Major Teaching and Academic Hospitals * Brand Marketing And Launch * Buy and Bill
  • Response Genetics
    Regional Sales Director, Midwest: Molecular Oncology Diagnostics
    Response Genetics Jul 2011 - Jul 2013
    | Lung Cancer | Colorectal Cancer | Breast Cancer| Melanoma Cancer | Gastric CancerDirector of Sales - Lead a team of 7 competitive sales professionals to exceed their sales goals and to achieve their professional career objectivesHiring, Leading, Budgeting, Branding, Sales Training, CRM, Market Analysis, Infrastructure, Marketing, Start ups, Territory Management, Selling Collateral. ResponseDX: Lung™, ResponseDX: Colon™, ResponseDX: Gastric™, ResponseDX: Melanoma™—to help physicians with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC) EGFR, EML4-ALK, c-Met, ROS-1, PI3Kinase, KRAS, ERCC-1; Colorectal Cancer (CRC) KRAS, BRAF, NRAS, PI3, MSI, c-Met, PI3Kinase, ERCC1, EGFR, TS; Gastric Cancer (GC) HER2; and Melanoma BRAF. Response Genetics, Inc. (“RGI”) (NASDAQ:RGDX) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens* Related Lung, Colon, Gastric, and Melanoma Agents/Knowledge: Erlotinib (Tarceva), Pemetrexed (Alimta), Cetuximab (Erbitux), Bevacizumab Injection (Avastin), Carboplatin (Platinum), Cisplatin (Platinum), FOLFOX (FOL– Folinic acid (leucovorin), Fluorouracil (5-FU), OX – Oxaliplatin (Eloxatin), FOLFIRI (IRI- Irinotecan), Gemcitabine, Crizotinib (XALKORI®), Vemurafenib (Zelboraf)* Call Points: Oncology, Pathology, Thoracic Surgeons, Interventional Radiology* Academic Call Points: University of Chicago, Northwestern, Rush, Loyola, UIC,Cook County, Hines VA* Community Oncologists* Digital Pathology* Hospital Contracting * Collaborative Research Studies with Major Teaching and Academic Hospitals* Brand Marketing And Launch * Buy and Bill
  • Eisai
    Senior Critical Care Oncology Account Manager
    Eisai Feb 2009 - Jul 2011
    Nutley, Nj, Us
    | Breast Cancer| Leukemia, Myelodysplastic Syndrome Cancer| Antiemetics - Chemotherapy Supportive Care| AnticoagulationHalaven, intravenous infusion (advanced, metastatic breast cancer); Dacogen, intravenous infusion (Hematologic pre-leukemia, Myelodysplastic Syndrome); Aloxi, injection (Palonosetron injection is used to prevent nausea and vomiting that may occur within 24 hours after receiving cancer chemotherapy or surgery); Fragmin, Injectable (anticoagulation, formulary and contracting)* Related Breast Cancer, Leukemia Agents/Knowledge:Taxanes, Anthracyclines, Xeloda, Avastin, Gemcitibine, Herceptin, and Tykerb, Vidaza, Lovenox, Fragmin* Call Points: Oncology, Director of Pharmacy, Clinical Coordinator, Buyer and Key PnT members and physicians: Surgery, Cardiology, Anticoagulation, Neurology, Nephrology, Orthopedics etc.* Reimbursement, Injectable (Fragmin) and Contract negotiations with Pull-Thru: System and Stand Alone* Buy and Bill
  • Valeant Pharmaceuticals
    Senior Neuroscience Consultant
    Valeant Pharmaceuticals Jul 2007 - Nov 2008
    Bridgewater, Nj, Us
    | Parkinson's Disease | Epilepsy| Severe Migraine* DIASTAT AcuDial is the first and only FDA-approved, acute at-home medication for patients two years and older on stable antiepileptic medications (AEDs) who experience bouts of increased seizure activity, sometimes called serial or cluster seizures or breakthrough seizures.* Zelapar® (selegiline hydrochloride) is indicated as an adjunct in the management of patients with Parkinson's disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy* Migranal® (dihydroergotamine mesylate, USP) Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura. Migranal is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine * Specialty Pharmacy Sales thru major Chicago teaching institutions* Successfully drove terriotory from bottom 5% to top 10 in the nation in less than 6 months-documented

Greg Ash Skills

Oncology Biotechnology Hematology Surgery Medical Diagnostics Clinical Trials Hospitals Cancer Critical Care Personalized Medicine Product Launch Colon Injectable Molecular Oncology Lung Cancer Clinical Research Buy And Bill Hospital Surgical Oncology Sales Management Strategic Planning Melanoma Venture Capital Start Ups Entrepreneurship Due Diligence Management Consulting Marketing Strategy Business Strategy Value Creation Healthcare Management Healthcare Consulting Executive Management Executive Coaching Coaching Molecular Diagnostics Pharmaceutical Sales

Greg Ash Education Details

  • Ball State University - Miller College Of Business
    Ball State University - Miller College Of Business
    Marketing Bs And Finance Bs

Frequently Asked Questions about Greg Ash

What company does Greg Ash work for?

Greg Ash works for Caris Life Sciences

What is Greg Ash's role at the current company?

Greg Ash's current role is Vice President | Strategy | Oncology | Sales Management | Marketing | Servant And Cross-functional Team Leadership | Strategic Thinking | Change Management | Lead.

What is Greg Ash's email address?

Greg Ash's email address is ga****@****ine.com

What is Greg Ash's direct phone number?

Greg Ash's direct phone number is +120152*****

What schools did Greg Ash attend?

Greg Ash attended Ball State University - Miller College Of Business.

What are some of Greg Ash's interests?

Greg Ash has interest in Weightlifting, Nutrition, Art, Personal Development, Reading, Fitness, Strategic Planning, Economics And Finance, Health.

What skills is Greg Ash known for?

Greg Ash has skills like Oncology, Biotechnology, Hematology, Surgery, Medical Diagnostics, Clinical Trials, Hospitals, Cancer, Critical Care, Personalized Medicine, Product Launch, Colon.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.